Celularity Inc
Veridion Score
Composite trend over time
Why is CELU moving today?
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for CELU.
CELU insider activity
Celularity Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$3K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | 2026-04-13 | Brigido Stephen | Insider | sell | $1.28 | 268 | 9,474 | $343 | SEC Form 4 |
| 2026-04-15 | 2026-04-13 | Haines John R | Insider | sell | $1.28 | 583 | 30,179 | $746 | SEC Form 4 |
| 2026-04-15 | 2026-04-13 | Hariri Robert J | Insider | sell | $1.28 | 1,182 | 2,853,553 | $2K | SEC Form 4 |
CELU contract awards, year to date.
Public federal awards linked to this ticker.
CELU lobbying filings, year to date.
Registered lobbying filings matched to Celularity Inc.